R&D Pipeline

Phase:

Therapy:

7 compounds matching your criteria
Compound/indication Phase 1 Phase 2 Phase 3 Filed
rFXIII Congenital deficiency

Haemostatic agent
rFVIII

Haemostatic agent
Fast-acting rFVIIa analogue

Haemostatic agent
rFXIII Cardiac surgery

Haemostatic agent
Long-acting rFVIIa derivative

Haemostatic agent
Long-acting rFIX derivative

Haemostatic agent
Subcutaneous, long-acting, rFVIIa derivative

Haemostatic agent
  •